Logo

Log In Sign Up |  An official publication of: American College of Emergency Physicians
Navigation
  • Home
  • Multimedia
    • Podcasts
    • Videos
  • Clinical
    • Airway Managment
    • Case Reports
    • Critical Care
    • Guidelines
    • Imaging & Ultrasound
    • Pain & Palliative Care
    • Pediatrics
    • Resuscitation
    • Trauma & Injury
  • Resource Centers
    • mTBI Resource Center
  • Career
    • Practice Management
      • Benchmarking
      • Reimbursement & Coding
      • Care Team
      • Legal
      • Operations
      • Quality & Safety
    • Awards
    • Certification
    • Compensation
    • Early Career
    • Education
    • Leadership
    • Profiles
    • Retirement
    • Work-Life Balance
  • Columns
    • ACEP4U
    • Airway
    • Benchmarking
    • Brief19
    • By the Numbers
    • Coding Wizard
    • EM Cases
    • End of the Rainbow
    • Equity Equation
    • FACEPs in the Crowd
    • Forensic Facts
    • From the College
    • Images in EM
    • Kids Korner
    • Medicolegal Mind
    • Opinion
      • Break Room
      • New Spin
      • Pro-Con
    • Pearls From EM Literature
    • Policy Rx
    • Practice Changers
    • Problem Solvers
    • Residency Spotlight
    • Resident Voice
    • Skeptics’ Guide to Emergency Medicine
    • Sound Advice
    • Special OPs
    • Toxicology Q&A
    • WorldTravelERs
  • Resources
    • ACEP.org
    • ACEP Knowledge Quiz
    • Issue Archives
    • CME Now
    • Annual Scientific Assembly
      • ACEP14
      • ACEP15
      • ACEP16
      • ACEP17
      • ACEP18
      • ACEP19
    • Annals of Emergency Medicine
    • JACEP Open
    • Emergency Medicine Foundation
  • About
    • Our Mission
    • Medical Editor in Chief
    • Editorial Advisory Board
    • Awards
    • Authors
    • Article Submission
    • Contact Us
    • Advertise
    • Subscribe
    • Privacy Policy
    • Copyright Information

Naloxone

  • Buprenorphine Explained, And Opioid Addiction Treatment Tips

    Editor’s Note: This is the third part of an ongoing series on what emergency physicians can do...
  • 5 Important Considerations for EMS Naloxone Administration

    1) Endpoints of Therapy: More is Not Always Better EMS providers may encounter patients with complete or...
  • U.S. Senators Question Kaleo’ $4,500 Tag on Opioid Overdose Treatment

    (Reuters) – U.S. Democrat Senator Claire McCaskill has asked Kaleo Pharmaceuticals to justify the more than 550...

Buprenorphine Explained, And Opioid Addiction Treatment Tips

June 26, 2018 - R. Corey Waller MD, MS FACEP, DFASAM - 2 Comments

Editor’s Note: This is the third part of an ongoing series on what emergency physicians can do…

Read More

5 Important Considerations for EMS Naloxone Administration

September 12, 2017 - Eric J. Cortez, MD, FAEMS; and John R. Casey, DO, MA, FACEP - 0 Comment

1) Endpoints of Therapy: More is Not Always Better EMS providers may encounter patients with complete or…

Read More

U.S. Senators Question Kaleo’ $4,500 Tag on Opioid Overdose Treatment

March 6, 2017 - Ankur Banerjee - 0 Comment

(Reuters) – U.S. Democrat Senator Claire McCaskill has asked Kaleo Pharmaceuticals to justify the more than 550…

Read More

Naloxone Distribution to Patients in Emergency Department Raises Controversy

June 15, 2016 - Catherine A. Marco, MD, FACEP; John E. Jesus, MD, FACEP; Joel M. Geiderman, MD, FACEP; and Eileen F. Baker, MD, FACEP - 1 Comment

The article “Naloxone Distribution Strategies Needed in Emergency Departments” by Samuels et al (ACEP Now, March 2016)…

Read More

Naloxone Distribution Strategies Needed in Emergency Departments

March 16, 2016 - Elizabeth A. Samuels, MD, MPH, Jason Hoppe, DO, Joan Papp, MD, FACEP; Lauren Whiteside, MD, MS, Ali S. Raja, MD, MBA, MPH, and Edward Bernstein, MD, FACEP - 1 Comment

The Case A 57-year-old man is brought in by family in a private vehicle after a “heroin…

Read More

World Health Organization Recommendations for Community Management of Opioid Overdose Reviewed by ACEP Clinical Policies Committee

February 4, 2016 - Graham S. Ingalsbe, MD - 1 Comment

Editor’s Note: The ACEP Clinical Policies Committee regularly reviews guidelines published by other organizations and professional societies….

Read More

Naloxone Nasal Spray Approved by FDA for Opioid Overdose Treatment

December 2, 2015 - Reuters - 0 Comment

The U.S. Food and Drug Administration approved the first-ever nasal spray emergency treatment for opioid overdose on…

Read More

Opinion: Prehospital Naloxone Administration Is Safe

April 14, 2015 - Elizabeth A. Samuels, MD, MPH, Stephen Aks, DO, FACMT, FACEP, Edward Bernstein, MD, FACEP, Esther Choo, MD, MPH, Kristin Dwyer, MD, Traci Green, PhD, MSc, Jason B. Hack, MD, FACEP, David Juurlink, BPhm, MD, PhD, FRCPC, Michael J. Mello, MD, MPH, FACEP, Megan Ranney, MD, MPH, FACEP, Alexander Walley, MD, MSc, and Lauren Whiteside, MD, MS - 2 Comments

In the January 2015 ACEP Now article “True Cost of Stopping Overdoses,” Paul Kivela, MD, MBA, PhD,…

Read More

Naloxone to Reduce Opiate Overdose Deaths Raises Cost, Liability, and Safety Concerns

January 20, 2015 - Paul Kivela, MD, MBA, FACEP - 1 Comment

The U.S. opiate epidemic leads to about 16,000 deaths a year. Activists have proposed solutions, and many…

Read More

Georgia Joins Ranks of States Supporting Naloxone Use in Overdose Cases

January 7, 2015 - Richard Quinn - 1 Comment

A relatively new Georgia law provides amnesty for people who show up to emergency departments to receive…

Read More
  • 1
  • 2

Wiley
  • Home
  • About Us
  • Contact Us
  • Privacy
  • Terms of Use
  • Advertise
  • Cookie Preferences
Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 2333-2603